# ARION (NCT03777813)

> Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03777813
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: UNICANCER
- Conditions: Esophagus Cancer; Unresectable Malignant Neoplasm
- Interventions: Durvalumab; IMRT 50 Gy + FOLFOX4 simplifIed (oxaliplatin, leucovorin, 5-FU)
- Enrollment: 112
- Primary outcome: cPFS (centrally reviewed cPFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=arion-nct03777813